BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.8B
AUM Growth
+$3.53B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1 +$122M
2 +$76M
3 +$74.4M
4
ALKS icon
Alkermes
ALKS
+$50.4M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$37.1M

Top Sells

1 +$145M
2 +$26.7M
3 +$21.2M
4
VERV
Verve Therapeutics
VERV
+$19M
5
BPMC
Blueprint Medicines
BPMC
+$16.1M

Sector Composition

1 Healthcare 99.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
26
Roivant Sciences
ROIV
$14.5B
$57M 0.41%
3,767,773
DNLI icon
27
Denali Therapeutics
DNLI
$2.86B
$54.2M 0.39%
3,731,695
MRUS icon
28
Merus
MRUS
$7.29B
$54.1M 0.39%
574,377
NTLA icon
29
Intellia Therapeutics
NTLA
$1.04B
$47.4M 0.34%
2,746,674
+71,000
REPL icon
30
Replimune Group
REPL
$784M
$46.3M 0.33%
11,045,336
RAPP
31
Rapport Therapeutics
RAPP
$1.42B
$45.9M 0.33%
1,547,090
+997,000
GPCR icon
32
Structure Therapeutics
GPCR
$2.17B
$43.6M 0.31%
1,556,109
-952,658
VRDN icon
33
Viridian Therapeutics
VRDN
$3.05B
$37.6M 0.27%
1,744,406
IONS icon
34
Ionis Pharmaceuticals
IONS
$13.4B
$37.1M 0.27%
+566,798
PRAX icon
35
Praxis Precision Medicines
PRAX
$4.91B
$36.5M 0.26%
689,488
GLUE icon
36
Monte Rosa Therapeutics
GLUE
$1.05B
$36.4M 0.26%
4,916,095
BNTX icon
37
BioNTech
BNTX
$24.8B
$36.4M 0.26%
368,923
NRIX icon
38
Nurix Therapeutics
NRIX
$1.79B
$35.9M 0.26%
3,882,125
DNTH icon
39
Dianthus Therapeutics
DNTH
$1.89B
$31.1M 0.22%
789,759
TRDA icon
40
Entrada Therapeutics
TRDA
$393M
$28.2M 0.2%
4,865,819
ARGX icon
41
argenx
ARGX
$56.1B
$27.9M 0.2%
37,760
RNA icon
42
Avidity Biosciences
RNA
$10.8B
$27.2M 0.2%
+625,000
PCVX icon
43
Vaxcyte
PCVX
$6.49B
$23.1M 0.17%
640,885
IRON icon
44
Disc Medicine
IRON
$3.52B
$22.3M 0.16%
337,050
CDTX icon
45
Cidara Therapeutics
CDTX
$6.91B
$21.8M 0.16%
227,272
CLDX icon
46
Celldex Therapeutics
CLDX
$1.8B
$17.2M 0.12%
665,370
NGNE icon
47
Neurogene
NGNE
$327M
$17.2M 0.12%
991,691
SERA icon
48
Sera Prognostics
SERA
$129M
$16.8M 0.12%
5,498,170
SYRE icon
49
Spyre Therapeutics
SYRE
$2.33B
$16.8M 0.12%
1,000,000
+373,297
CERS icon
50
Cerus
CERS
$338M
$15.9M 0.12%
10,008,345
-2,875,499